Developing rpa microfluidic device for rapid detection of hcv as point-of-care test .

• At: Glasgow (Scotland) (2018)
• Type: Poster
• Poster code: POS-BIO-003
• By: ZYADA, Ebrahim (Misr University for Science and Technology, Clinical Pharmacy)
• Co-author(s): Ebrahim Mohamed Zyada: Misr University for Science and Technology, Cairo, Egypt
  Shreen Helal: MSA University, Cairo, Egypt
  
• Abstract:

  Background

  Nucleic acid amplification is the most sensitive and specific method to detect (HCV) .However the polymerase chain reaction remains laboratory-based and has to be conducted by trained personnel , needs expensive equipment and can't be applied as point-of-care test  .

  Methods

  The new method depends on  Recombinase Polymerase Amplification
  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login